Skip to main content
Premium Trial:

Request an Annual Quote

BGI Opens New Copenhagen Genome Research Center

NEW YORK (GenomeWeb News) – BGI today launched a new genomics research center in Copenhagen, marking its first such center in Europe.

The 13,000 square-foot European Genome Research Center, situated in the Copenhagen Bio Science Park at the University of Copenhagen, will focus on establishing collaborations to advance genomics in healthcare, bioenergy, agriculture, and other research areas.

BGI had announced the establishment of a European office in the Danish capital, as well as a US office in Cambridge, Mass., in May 2010. But today's announcement marks the official opening of the new genome research center.

The center is stocked with 10 Illumina HiSeq 2000 sequencers, said BGI, and will house two integrated projects including an effort to identify cancer pathogens for research into cancer vaccines and another to establish a catalog of genetic variations among Danish people.

"Our primary mission of this research center is to provide BGI´s world-class expertise and infrastructure for the European researchers in genomics, proteomics, bioinformatics and other related areas," BGI Europe Director Ning Li said in a statement. "I believe this center also will strive to cultivate joint collaborations between China and Europe."

"The vision is to create the best facilities in the fields of genomics and bioinformatics, so that we have an opportunity to utilize knowledge on genomics and better Denmark's possibilities of preventing and curing diseases. We hope that it will be possible, for example, to develop a vaccine against cancer," University of Copenhagen Vice Chancellor Thomas Bjørnholm added.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.